Effects of ultrasound-guided stellate ganglion pulse radiofrequency on the selective nerve root pulse radiofrequency in patients with cervical spondylotic radiculopathy
李美睿,李喆雪,田智焕,赵婷伟,孙筱筱,张广建
DOI: https://doi.org/10.3760/cma.j.cn101658-20221006-00150
2023-01-01
Abstract:Objective:To observe effects of ultrasound-guided stellate ganglion pulse radiofrequency on the selective nerve root pulse radiofrequency in patients with cervical spondylotic radiculopathy (CSR).Methods:Fifty patients with CSR, aged>55 years old, duration >1 month, numerical rating scale (NRS)≥4, were collected in Department of Painology, Yanbian University Affiliated Hospital from March 1st, 2019 to March 1st, 2020, and the patients were divided into selective nerve root RF group (RF group) and selective nerve root radiofrequency combined with stellate ganglion pulse radiofrequency group (RF combination group) by random number table method, 25 cases in each group. The patients received pulse radiofrequency at C 6 nerve root under ultrasound guidance in the RF group, and received pulse radiofrequency at C 6 nerve root combined with stellate ganglion pulse radiofrequency in the RF combination group. Before the treatment, 1 d, 1 week and 1, 3, 6 and 12 months after the treatment, NRS, numbness score, and CSA-GAS score were recorded. The average blood flow velocity, resistance index, blood flow of the affected brachial artery were recorded before the treatment, 1 week and 1, 3, 6 and 12 months after the treatment. The efficacy was evaluated at 6 and 12 months after the treatment. Complications such as dizziness, numbness and hematoma were observed during the treatment. Results:There was no significant difference in the general data between the two groups (all P>0.05). Compared with pre-treatment, NRS was decreased at each time point after the treatment in the two groups (all P<0.05). NRS was lower in the RF combination group than that in the RF group at 1 week and 1, 3, 6, 12 months after the treatment (all P<0.05). Compared with the RF group, the number of NRS 0-3 points was significantly increased in the RF combination group at 3, 6 and 12 months after the treatment (all P<0.05). Compared with pre-treatment, the numbness score significantly decreased at 1, 3, 6 and 12 months after the treatment in the RF combination group (all P<0.05). Compared with pre-treatment, CSA-GAS significantly increased at 1 week and 1, 3, 6 months after the treatment in the two groups (all P<0.05), and CSA-GAS were higher in the RF combination group than that in the nerve root RF group at all time points (all P<0.05). The average blood flow velocity and blood flow of the affected brachial artery increased at 1, 3, 6 and 12 months after the treatment than that pre-treatment in the RF combination group (all P<0.05); the resistance index decreased (all P<0.05), and the RF combination group was superior to the RF group (all P<0.05). At 12 months after the treatment, the effective and good rate was better in the RF combination group than that in the RF group[92.0% (23/25 cases) vs. 76.0% (19/25 cases), χ2=0.57, P=0.039]. No serious complication reactions were observed in both groups. Conclusion:Stellate ganglion pulse radiofrequency can safely and effectively improve the clinical efficacy of ultrasound-guided selective nerve root pulse radiofrequency in patients with CSR, by improving the blood flow of the affected limb.